MINIMAL RESIDUAL DISEASE
Clinical trials for MINIMAL RESIDUAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new MINIMAL RESIDUAL DISEASE trials appear
Sign up with your email to follow new studies for MINIMAL RESIDUAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Donor cells join fight against nasopharyngeal cancer recurrence
Disease control Not yet recruitingThis early-phase trial tests whether adding natural killer (NK) cells from healthy donors to standard chemoradiotherapy can lower the chance of cancer returning in 31 people with advanced nasopharyngeal cancer. The study first finds the safest dose of NK cells, then checks if the…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Singapore General Hospital • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Could chemo before surgery beat standard care for colon cancer?
Disease control Not yet recruitingThis study compares giving chemotherapy before surgery versus standard surgery-first treatment for people with stage II or III colon cancer that has a high risk of coming back. About 100 adults aged 18-70 will be randomly assigned to one of two groups. The goal is to see if pre-s…
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
Blood test may predict liver cancer comeback
Knowledge-focused Not yet recruitingThis study looks at whether a simple blood test can detect leftover cancer cells after liver cancer surgery. It involves 276 adults with high-risk liver cancer. The goal is to see if the test can predict if the cancer will come back and who might benefit from extra immunotherapy …
Matched conditions: MINIMAL RESIDUAL DISEASE
Phase: NA • Sponsor: Tongji Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC